Prostate cancer is one of the main malignant tumors for middle-aged and elderly men in my country. According to statistics, the incidence of prostate cancer ranks sixth among male malignant tumors in my country, surpassing bladder cancer as the first among male urinary tract tumors, and it is increasing day by day. trend. Early prostate cancer is asymptomatic, and when symptoms appear, it is basically advanced. Some patients missed treatment opportunities because of this. Therefore, it is necessary to carry out publicity and routine screening of prostate cancer knowledge for specific populations, so as to achieve the purpose of early diagnosis and early treatment, and extend the life of patients.

Confirmed to be cancer, collapsed!

In 2009, because of frequent urination and urgency, Mr. Zhang went to the hospital for an examination. The results of the examination showed that Mr. Zhang’s PSA index was higher than normal. Mr. Zhang thought that there was no major problem, so he quickly ignored it.

Six months later, he went to the hospital for an examination again, and the results of this examination left Mr. Zhang dumbfounded. Because he has developed prostate cancer.

A series of terrifying terms "prostate cancer, malignant tumor, advanced stage, metastasis" surrounded Mr. Zhang's ears, causing him to panic. Through the patient's explanation of the doctor, Mr. Zhang underwent surgery and then received anti-hormonal treatment. But three months later, on a review, it was found that his prostate cancer had recurred, and there were bone metastases and lymph nodes.
 
Don’t give up, there will always be miracles

After learning about Mr. Zhang's medical history, imaging data, and pathological evaluation, Mr. Zhang received chemotherapy and radiotherapy in subsequent follow-ups, but there was no obvious effect, and his condition worsened. When Mr. Zhang felt that he could not live long, he accidentally learned about the ACTL treatment technology. After various understandings and consultations, Mr. Zhang received ACTL treatment. After the treatment of Mr. Zhang’s condition, the ACTL immunotherapy with PSA and PSMA antigens was the main treatment. Significant improvement, hormone therapy was effective again, and the PET-CT reexamination results six months after treatment indicated that nearly 98% of the metastatic lesions disappeared. After a return visit, Mr. Zhang has survived for 8 years.

Here are the details of the patient:

Imaging changes before and after ACTL treatment: